What are the long-term outcomes of neonates with hypoxic-ischemic encephalopathy (HIE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Long-term Outcomes of Neonates with Hypoxic-Ischemic Encephalopathy

Neonates with hypoxic-ischemic encephalopathy (HIE) face significant risks of death and neurodevelopmental impairment, with outcomes varying based on severity, treatment, and presence of additional brain pathology. Despite therapeutic hypothermia improving outcomes, many survivors still experience long-term neurological deficits 1, 2.

Mortality and Overall Outcomes

  • HIE is a leading cause of neonatal mortality and morbidity worldwide 2
  • Therapeutic hypothermia has significantly reduced death and severe disabilities in term newborns with moderate-to-severe HIE 3
  • Recent evidence shows therapeutic hypothermia reduces the combined outcome of death or neurodevelopmental impairment (NDI) at 18-24 months (RR 0.67,95% CI 0.45-0.99) 1
  • Despite therapeutic hypothermia, mortality remains high in severe cases 4

Neurodevelopmental Outcomes by Severity

Severe HIE

  • Highest risk for death or severe neurodevelopmental impairment
  • In early 1980s studies (pre-hypothermia era), only 35% of infants survived 3-5 years, and only 29% of survivors were without major impairment 1
  • Even with therapeutic hypothermia, severe HIE continues to have poor outcomes

Moderate HIE

  • Therapeutic hypothermia significantly improves outcomes
  • Without treatment, substantial risk of neurodevelopmental impairment
  • With therapeutic hypothermia, risk of death or severe disability is reduced by approximately 15% (absolute risk reduction) 1

Mild HIE

  • Traditionally thought to have favorable outcomes
  • Recent evidence suggests untreated mild HIE may carry significant risk for abnormal neurodevelopmental outcomes 2
  • Children with mild HIE require follow-up as cognitive deficits may emerge later

Specific Neurological Sequelae

Motor Function

  • Cerebral palsy is a common outcome in survivors, particularly with severe HIE
  • Motor deficits correlate with pattern and severity of brain injury on MRI
  • Term neonates typically have injury affecting the cortex, basal ganglia, and internal capsule 5

Cognitive Function

  • Normal neurodevelopmental outcomes in early childhood do not preclude cognitive difficulties in late childhood and adolescence 3
  • Cognitive impairments may emerge later as higher-order functions develop
  • Children with history of HIE remain at risk for cognitive impairments even after hypothermia therapy 3

Seizures and Epilepsy

  • HIE is the most common cause of neonatal seizures (46-65% of cases) 5
  • Risk of epilepsy persists long-term, particularly in those with severe brain injury
  • Seizures within first 48 hours are most commonly due to HIE 5

Sensory Impairments

  • Visual and hearing impairments are common in survivors with moderate-to-severe HIE
  • Children with unilateral periventricular hemorrhagic infarction (PVHI) and VP shunt have higher rates of visual impairment (37%) 1

Prognostic Factors

  • MRI findings strongly correlate with long-term outcomes
  • Absence of major cerebral lesions on MRI is highly predictive of normal neurological outcome 5
  • Additional brain pathology (e.g., cystic periventricular leukomalacia or intraventricular hemorrhage) worsens prognosis 1
  • Ventricular dilation impacts neurodevelopmental outcomes primarily when additional brain pathology is present 1

Impact of Therapeutic Hypothermia

  • Standard treatment for moderate-to-severe HIE in term and late-preterm infants (≥35 weeks gestation) 5
  • Cooling to 33.5°C for 72 hours significantly improves outcomes 5
  • Number needed to treat to prevent one death or case of neurodevelopmental impairment: 7 (95% CI 4-200) 1
  • Despite therapeutic hypothermia, survivors remain at risk for cognitive impairments requiring long-term follow-up 3

Long-term Follow-up Considerations

  • Follow-up should continue throughout late childhood and adolescence, even for children with normal early assessments 3
  • Attention deficit disorders may emerge in adolescence 1
  • Cognitive and behavioral difficulties may not be apparent until school age when higher cognitive functions develop 3
  • MRI patterns may help predict specific neurodevelopmental outcomes and guide targeted interventions 3

HIE remains a significant cause of neurological disability despite advances in treatment. Early identification, prompt therapeutic hypothermia when indicated, and comprehensive long-term follow-up are essential to optimize outcomes for affected children.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Neonatal Care

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.